Do you or a loved one have treatment resistant depression?
-provider referrals
-direct patient inquiries
Contact us:
email:
evergreentms@outlook.com
phone:
(360) 385-9818
fax:
(360) 385-1496
​
Transcranial Magnetic Stimulation
​
In early Clinical trials:
- 58% of patients respond, 37% have remittance of symptoms, 1. Carpenter et al, 2010
In Newer Larger Clinical trials:
- of over 3800 patients who had completed at least 20 sessions 63-70%of patients reported significant response and 25-35% reported remission of symptoms,
2. Sackheim et al, 2010*
​
Remission = depression score of less than 5 on 27 point scale
​
Response = reduction of depression symptoms by 50% or more
​
Get FDA Approved Help for Your Treatment Resistant Depression
Why TMS?
-
No systemic side effects - insomnia, fatigue, blurred vision, GI distress, sexual dysfunction, dry mouth, tremor, autonomic instability, etc. (as with medications)
-
No known cognitive side effects
-
Noninvasive - No need for sedation, anesthesia, hospitalization, or recovery time (as with ECT, DBS, VNS)
-
Effective in treatment resistant depression (TRD) where medications can have diminishing returns1,2,3,4
-
Covered (with copay) by most insurances including Medicare, our office currently accepts out of pocket, Aetna, Regence Blue Shield, Sound Health and Wellness, First Choice, and Medicare
1.
L.L. Carpenter, P.G. Janicak, S.T. Aaronson, T. Boyadjis, D.G. Brock, I.A. Cook, D.L. Dunner, K. Lanocha, H.B. Solvason, M.A. Demitrack
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice
Depress. Anxiety, 29 (2012), pp. 587-5961
​
2.
Sackeim HA, Aaronson ST, Carpenter LL, Hutton TM, Mina M, Pages K, Verdoliva S, West WS. Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation. J Affect Disord. 2020 Dec 1;277:65-74. doi: 10.1016/j.jad.2020.08.005. Epub 2020 Aug 7. PMID: 32799106.
​